<DOC>
	<DOCNO>NCT02789033</DOCNO>
	<brief_summary>The prevalence diabetic foot ulceration diabetic population 4-10 % ; condition frequent elder patient . It estimate 5 % patient diabetes present history foot ulceration , lifetime risk diabetic patient develop complication 15 % . The majority ( 60-80 % ) foot ulcer heal , 10-15 % remain active , 5-24 % finally lead limb amputation within period 6-18 month first evaluation , 2 3 patient limb amputation could also involve new amputation next year ; high leg , Eighty-five percent lower-limb amputation patient diabetes precede foot ulceration . The management chronic diabetic foot ulcer ( DFU ) suggest multi-disciplinary approach include control diabetes , orthotic shoe wear , off-loading device , wound care surgery select case . However , treatment DFU remain challenge unsatisfactory result surgical non-surgical treatment . Many adjunctive therapy design improve care DFU include negative pressure wound therapy , ultrasound , recombinant human platelet-derived growth factor-BB ( rPDGF-BB ) Hyperbaric oxygen acellular matrix product among others .</brief_summary>
	<brief_title>Efficacy Combination Isosorbide Dinitrate Spray Chitosan Diabetic Foot Ulcers</brief_title>
	<detailed_description>A randomize , placebo control , double-blind Clinical trial design . 60 Patients diabetic foot ulcer grade I II classification Wagner , leg arm index &gt; 0.8 without specific treatment foot ulcer refer experimental clinical Therapeutic Institute include . All patient give write informed consent ; previously protocol approved bioethics committee CUCS , Guadalajara University , registration number 030-2010 . Patients another type topical medication exclude . Isosorbide dinitrate spray ( 2.5 mg ) . Preparation chitosan Hydrogels : The composition gel formulation give prior training . ISDN chitosan gel apply handle aseptic condition wind , cover sterile bandage . The patient evaluate every 2 week ( macroscopic study measurement ulcerated area ) 6 view . A second biopsy do one week finalization treatment 15 week . The biopsy embed paraformaldehyde ( 4 % ) paraffin . Sections 5 µm analyzed pathologist determine hypertrophic hyperplasic capillary , inflammation cellular matrix use Hematoxylin &amp; eosin Masson 's trichrome stain . An immunohistochemical stain also realize evaluate several molecular marker α-SMA ( abcam , Cambridge , MA ) , Desmin ( abcam , Cambridge , MA ) , VEGF ( abcam , Cambridge , MA ) Von Willebrand Factor ( Chemicon , CA ) . ( figure 1 ) Statistical analysis : It do use SPSS program Windows Version 10.0 , result quantitative variable express average standard deviation . The difference baseline subsequent pharmacologic intervention measurement investigate Wilcoxon test . The Mann Whitney U test use compare group . Frequencies category well percentage quantify qualitative variable . Comparisons group perform Chi2 . For comparison p &lt; 0.05 consider significant .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Chitosan</mesh_term>
	<criteria>Patients diabetic foot ulcer grade I II classification Wagner leg arm index &gt; 0.8 without specific treatment foot ulcer refer experimental clinical Patients another type topical medication patient diabetic foot ulcer grade III leg arm index &lt; 0.8</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>chitosan</keyword>
	<keyword>isosorbide dinitrate spray</keyword>
</DOC>